In situ adenocarcinoma and squamous carcinoma of uterine cervix. Pathological and immunohistochemical analysis with cytokeratin 13

Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):249-53. doi: 10.1016/j.ejogrb.2006.07.047. Epub 2006 Sep 1.

Abstract

Objectives: The aim of the study was the pathological and immunohistochemical analysis of cytokeratin 13 (CK13) in intraepithelial cervical tumors.

Study design: We studied 415 in situ squamous carcinomas and 13 in situ mucinous cervical type adenocarcinomas of the uterine cervix. All patients underwent laser cervical conization and had a follow-up ranging 12-135 months.

Results: 3% of the squamous carcinoma patients recurred during the follow-up period, while the percentage of recurrence of in situ adenocarcinoma patients was 7.6%. We observed positive surgical edges in 46.1% of glandular tumors, and in 5% of squamous tumors. The percentage of recurrence was high among the cases with positive borders independently from their histopathologic type (14.3% in the squamous carcinomas versus 50% in the adenocarcinomas), compared to cases with negative edges (2.3% in the squamous carcinomas versus 0% in the adenocarcinomas). We observed CK13 positive staining in cervical squamous tumors and in mucinous cervical type adenocarcinomas, while there was no positive staining in non-neoplastic cervical glandular elements.

Conclusion: CK13 positive immunostaining among in situ squamous and in situ mucinous cervical type adenocarcinoma cases adds additional evidence to data supporting a common origin of the two lesions.

MeSH terms

  • Adenocarcinoma, Mucinous / metabolism*
  • Adult
  • Carcinoma in Situ / metabolism*
  • Carcinoma, Squamous Cell / metabolism*
  • Cohort Studies
  • Female
  • Humans
  • Immunohistochemistry
  • Keratin-13 / metabolism*
  • Middle Aged
  • Retrospective Studies
  • Uterine Cervical Neoplasms / metabolism*

Substances

  • Keratin-13